Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
1.520
+0.040 (2.70%)
At close: Aug 29, 2025, 4:00 PM
1.490
-0.030 (-1.97%)
After-hours: Aug 29, 2025, 4:14 PM EDT

Camp4 Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Net Income
-51.78-51.79-49.29-44.19
Depreciation & Amortization
1.691.71.680.88
Stock-Based Compensation
4.254.032.911.38
Other Operating Activities
1.921.831.821.69
Change in Accounts Payable
0.210.17-1.121.33
Change in Unearned Revenue
-0.39--
Change in Other Net Operating Assets
-1.9-1.88-0.150.37
Operating Cash Flow
-45.61-45.56-44.16-38.54
Capital Expenditures
-0.54-0.44-0.68-4.03
Investing Cash Flow
-0.54-0.44-0.68-4.03
Long-Term Debt Issued
--0.71-
Long-Term Debt Repaid
--0.82-0.59-0.09
Net Debt Issued (Repaid)
-0.5-0.820.12-0.09
Issuance of Common Stock
76.4676.470.190.06
Other Financing Activities
-3.37-3.98--
Financing Cash Flow
72.671.660.3100.16
Net Cash Flow
26.4525.66-44.5357.59
Free Cash Flow
-46.15-46-44.83-42.57
Free Cash Flow Margin
-1534.82%-7055.67%-12809.43%-
Free Cash Flow Per Share
-3.18-9.81-113.51-136.31
Levered Free Cash Flow
-28.34-26.54-30.18-
Unlevered Free Cash Flow
-28.33-26.52-30.16-
Change in Working Capital
-1.69-1.33-1.271.7
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q